Kevin L Winthrop

Author PubWeight™ 80.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012 12.07
2 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010 10.03
3 Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 2011 3.58
4 Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009 3.09
5 Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg 2012 2.95
6 The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013 2.80
7 Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 2012 2.51
8 Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002 2.03
9 Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis 2011 1.94
10 Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012 1.78
11 Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med 2013 1.78
12 Variable agreement among experts regarding Mycobacterium avium complex lung disease. Respirology 2014 1.47
13 Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 2012 1.43
14 Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis 2012 1.33
15 Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf 2011 1.30
16 Toxoplasmosis: a global threat. J Glob Infect Dis 2011 1.19
17 Ocular toxoplasmosis II: clinical features, pathology and management. Clin Experiment Ophthalmol 2012 1.15
18 Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012. Ann Am Thorac Soc 2015 1.08
19 Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012. Ann Rheum Dis 2013 1.05
20 Exposure to rodents and rodent-borne viruses among persons with elevated occupational risk. J Occup Environ Med 2002 1.00
21 Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA. Emerg Infect Dis 2011 0.99
22 You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need. Ann Rheum Dis 2012 0.99
23 Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia. Am J Respir Crit Care Med 2012 0.97
24 Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum 2013 0.96
25 Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositis. J Rheumatol 2008 0.95
26 Influenza, Winter Olympiad, 2002. Emerg Infect Dis 2006 0.95
27 Training of an ophthalmologist in concepts and practice of community eye health. Indian J Ophthalmol 2012 0.93
28 Update on rheumatic manifestations of infectious diseases. Curr Opin Rheumatol 2010 0.92
29 Pulmonary disease associated with nontuberculous mycobacteria, Oregon, USA. Emerg Infect Dis 2011 0.91
30 Mycobacteria in nail salon whirlpool footbaths, California. Emerg Infect Dis 2005 0.90
31 Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect 2012 0.90
32 Let the fog be lifted: screening for hepatitis B virus before biological therapy. Ann Rheum Dis 2011 0.87
33 Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's view. Future Microbiol 2010 0.86
34 Ocular toxoplasmosis I: parasitology, epidemiology and public health. Clin Experiment Ophthalmol 2012 0.85
35 Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Curr Opin Rheumatol 2011 0.85
36 Mycobacterium avium complex lung disease therapy. Am J Respir Crit Care Med 2012 0.84
37 Tuberculosis of the nasolacrimal duct. Ophthal Plast Reconstr Surg 2011 0.83
38 Strenotrophomonas maltophilia-related chronic dacryocystitis. Orbit 2012 0.83
39 Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014 0.82
40 Association between anti-TNF-α therapy and interstitial lung disease. Pharmacoepidemiol Drug Saf 2013 0.81
41 Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007-2012. Emerg Infect Dis 2017 0.80
42 Physician attitudes regarding school-located vaccination clinics. J Sch Health 2013 0.80
43 Opinions differ by expertise in Mycobacterium avium complex disease. Ann Am Thorac Soc 2014 0.79
44 Treatment of Mycobacterium abscessus Infection. Emerg Infect Dis 2016 0.78
45 Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders. Clin Infect Dis 2009 0.78
46 Vaccinations for rheumatoid arthritis. Curr Rheumatol Rep 2014 0.78
47 Patients with nontuberculous mycobacteria: comparison of updated and previous diagnostic criteria for lung disease. Diagn Microbiol Infect Dis 2012 0.78
48 "Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti-tumor necrosis factor alpha drugs: a nested case-control study". BMC Infect Dis 2013 0.77
49 The emergence of retinopathy of prematurity in Guatemala. J Pediatr Ophthalmol Strabismus 2010 0.77
50 Travel-associated antimicrobial drug-resistant nontyphoidal Salmonellae, 2004-2009. Emerg Infect Dis 2014 0.77
51 Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy. Rheumatology (Oxford) 2013 0.76
52 Mycobacterium chelonae facial infections following injection of dermal filler. Aesthet Surg J 2013 0.75
53 Reply: To PMID 22967869. Am J Ophthalmol 2013 0.75
54 Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013. Emerg Infect Dis 2017 0.75
55 Therapy: Off-label biologics use and infection risk-the great unknown. Nat Rev Rheumatol 2011 0.75
56 Tuberculosis cases associated with infliximab and etanercept. Clin Infect Dis 2004 0.75
57 Implications for biologic therapy: Staphylococcus aureus decolonization of individuals with a history of recurrent skin and soft-tissue infections. JAMA Dermatol 2013 0.75
58 The emerging safety profile of JAK inhibitors in rheumatic disease. Nat Rev Rheumatol 2017 0.75
59 Mycobacterium marinum presenting as large verrucous plaques on the lower extremity of a South Pacific Islander. Am J Trop Med Hyg 2008 0.75
60 Angiosarcoma of the Eyelid With Superimposed Enterobacter Infection. Ophthal Plast Reconstr Surg 2016 0.75
61 Surveillance of Extrapulmonary Nontuberculous Mycobacteria Infections, Oregon, USA, 2007-2012. Emerg Infect Dis 2017 0.75